Cardiovascular Journal of Africa: Vol 28 No 3 (May/June 2017)

35 / 80

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 3, May/June 2017 AFRICA 169
4. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;
340: 115–126.
5. Sattar N. Inflammation and endothelial dysfunction: intimate compan-
ions in the pathogenesis of vascular disease? Clin Sci 2004; 106: 443–445.
6. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP,
et al. Endothelium-derived nitric oxide regulates arterial elasticity in
human arteries in vivo. Hypertension 2001; 38: 1049–1053.
7. Polovina MM, Potpara TS. Endothelial dysfunction in metabolic and
vascular disorders, Postgrad Med 2014; 126: 38–53.
8. Steinmann M, Abbas C, Singer F, Casaulta C, Regamey N, Haffner D,
et al. Arterial stiffness is increased in asthmatic children. Eur J Pediatr
2015; 174: 519–523.
9. Arnett DK, Evans GW, Riley WA. Arterial stiffness a new cardiovascu-
lar risk factor. Am J Epidemiol 1994; 140: 669–682.
10. Suissa S, Assimes T, Brassard P, Ernst P Inhaled corticosteroid use in
asthma and the prevention of myocardial infarction. Am J Med 2003;
115: 377–381.
11. Hanania NA, Moore RH. Anti-inflammatory activities of beta2-
agonists. Curr Drug Targets Inflamm Allergy 2004; 3(3): 271–277.
12. Montelukast sodium. The American Society of Health-System
Pharmacists. Retrieved 3 April 2011.
13. From the Global Strategy for Asthma Management and Prevention,
Global Initiative for Asthma (GINA) 2012. Available from: http://www.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka
PA, et al. Recommendations for chamber quantification: a report from
the American Society of Echocardiography’s Guidelines and Standards
Committee and the Chamber Quantification Writing Group, developed
in conjunction with the European Association of Echocardiography, a
branch of the European Society of Cardiology. J Am Soc Echocardiogr
2005; 18: 1440–1463.
15. Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C,
Trautnitz M, et al. Brain natriuretic peptide is a prognostic parameter
in chronic lung disease. Am J Respir Crit Care Med 2006; 173: 744–750.
16. Elmasry OA, Attia HM, Abdelfattah NM. Assessment of left ventricu-
lar diastolic function in bronchial asthma: Can we rely on transmitral
inflow velocity patterns? Eur J Echocardiogr 2008; 7: 178–190.
17. Massoud MN, el Nawawy AA, el Nazar SY, Abdel-Rahman GM.
Tumour necrosis factor-alpha concentration in severely asthmatic chil-
dren. East Mediterr Health J 2000; 6: 432–436.
18. Manthous CA. Management of severe exacerbations of asthma. Am J
Med 1995; 99: 298–308.
19. Robin ED, McCauley R. Sudden cardiac death in bronchial asthma and
inhaled beta-adrenergic agonists. Chest 1992; 101: 1699–1702
20. Au DH, Lemaitre RN, Curtis JR, Smith NL, Psaty BM. The risk of
myocardial infarction associated with inhaled B-adrenoceptor agonists.
Am J Respir Crit Care Med 2000; 161: 827–830.
21. Martin RM, Dunn NR, Freemantle SN, Mann RD. Risk of nonfatal
cardiac failure and ischaemic heart disease with long acting B2 agonists.
Thorax 1998; 53: 558–621.
22. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ.
Inhaled corticosteroids: past lessons and future issues. J Allergy Clin
Immunol 2003; 112: 1–40.
23. Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-
Gutthann S. Use of oral corticosteroids and the risk of acute myocardial
infarction. Atherosclerosis 2007; 192: 376–383.
24. Makheja AN, Bloom S, Muesing R, Simon T, Bailey JM. Anti-
inflammatory drugs in experimental atherosclerosis. 7. Spontaneous
atherosclerosis in WHHL rabbits and inhibition by cortisone acetate.
Atherosclerosis 1989; 76: 155–161.
25. Camargo CA Jr, Barr RG, Chen R, Speizer FE. Prospective study
of inhaled corticosteroid use, cardiovascular mortality, and all-cause
mortality in asthmatic women. Chest 2008; 134: 546–551.
26. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC,
Rebsamen MC. Acute cardiovascular protective effects of corticoster-
oids are mediated by non- transcriptional activation of endothelial nitric
oxide synthase. Nat Med 2002; 8: 473–479.
27. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander
I, et al. Airway inflammation in mild intermittent and in persistent
asthma. Am J Respir Crit Care Med 1998; 157: 403–409.
28. Grisham MB, Jourd’heuil D, Wink DA. Chronic inflammation and
reactive oxygen and nitrogen metabolism implications in DNA damage
and mutagenesis. Aliment Pharmacol Ther 2000; 14: 3–9.
29. Libby P. Inflammation in atherosclerosis. Nature 2002: 868–874.
30. Otsuki M, Miyatake A, Fujita K, Hamasaki T, Kasayama S. Reduced
carotid atherosclerosis in asthmatic patients treated with inhaled corti-
costeroids. Eur Respir J 2010; 36: 503–508.
31. Schillaci G, Bartoloni E, Pucci G, Pirro M, Settimi L, Alunno A, et al .
Aortic stiffness is increased in polymyalgia rheumatica and improves
after steroid treatment. Ann Rheum Dis 2012; 71: 1151–1156.
32. Lacombe F, Dart A, Dewar E, Jennings G, Cameron J, Laufer E.
Arterial elastic properties in man: A comparison of echo-Doppler indi-
ces of aortic stiffness. Eur Heart J 1992; 13: 1040–1045.
33. Levent E, Gökşen D, Ozyürek AR. Stiffness of the abdominal aorta in
obese children. J Pediatr Endocrinol Metab 2002; 15: 405–409.
34. Ulger Z, Aydinok Y, Gurses D, Levent E, Ozyurek AR. Stiffness of the
abdominal aorta in beta-thalassemia major patients related with body
iron load. J Pediatr Hematol Oncol 2006; 28: 647–652.
35. Hirono O, Kubota I, Minamihaba O, Fatema K, Kato S, Nakamura H,
et al. Left ventricular diastolic dysfunction in patients with bronchial
asthma with long-term oral beta2-adrenoceptor agonists. Am Heart J
2001; 142: 11.